Fig. 6From: SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomySchematic map of methylation information for all sites in tumor tissues and normal tissues. Asterisk represents Kruskall-Wallis P value < 0.05Back to article page